Cassar Lucy, Nicholls Craig, Pinto Alex R, Chen Ruping, Wang Lihui, Li He, Liu Jun-Ping
Molecular Signaling Laboratory, Department of Immunology, Central Eastern Clinical School, Monash University, Prahran, VIC, 3181, Australia.
Institute of Aging Research, Hangzhou Normal University School of Medicine, Hangzhou, 311121, Zhejiang Province, China.
Protein Cell. 2017 Jan;8(1):39-54. doi: 10.1007/s13238-016-0322-1. Epub 2016 Sep 30.
Human telomerase reverse transcriptase (hTERT) plays a central role in telomere lengthening for continuous cell proliferation, but it remains unclear how extracellular cues regulate telomerase lengthening of telomeres. Here we report that the cytokine bone morphogenetic protein-7 (BMP7) induces the hTERT gene repression in a BMPRII receptor- and Smad3-dependent manner in human breast cancer cells. Chonic exposure of human breast cancer cells to BMP7 results in short telomeres, cell senescence and apoptosis. Mutation of the BMPRII receptor, but not TGFbRII, ACTRIIA or ACTRIIB receptor, inhibits BMP7-induced repression of the hTERT gene promoter activity, leading to increased telomerase activity, lengthened telomeres and continued cell proliferation. Expression of hTERT prevents BMP7-induced breast cancer cell senescence and apoptosis. Thus, our data suggest that BMP7 induces breast cancer cell aging by a mechanism involving BMPRII receptor- and Smad3-mediated repression of the hTERT gene.
人端粒酶逆转录酶(hTERT)在端粒延长以实现细胞持续增殖过程中发挥核心作用,但目前尚不清楚细胞外信号如何调节端粒酶对端粒的延长作用。在此我们报告,细胞因子骨形态发生蛋白7(BMP7)在人乳腺癌细胞中以依赖BMPRII受体和Smad3的方式诱导hTERT基因表达受抑。人乳腺癌细胞长期暴露于BMP7会导致端粒缩短、细胞衰老和凋亡。BMPRII受体而非TGFβRII、ACTRIIA或ACTRIIB受体的突变会抑制BMP7诱导的hTERT基因启动子活性的抑制,导致端粒酶活性增加、端粒延长以及细胞持续增殖。hTERT的表达可防止BMP7诱导的乳腺癌细胞衰老和凋亡。因此,我们的数据表明,BMP7通过一种涉及BMPRII受体和Smad3介导的hTERT基因抑制的机制诱导乳腺癌细胞衰老。